Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) is a key partner in the #RBDCOV project, applying their extensive clinical experience to analyse T cell responses using Intracellular Cytokine Assay (ICS) technology. Discover how this technology works in our latest specialised article! 🔴👉 https://lnkd.in/diyXDXZ3 #InnovatioKillsTheVirus
RBDCOV_EU
Public Health
RBDCOV aims to test the efficacy, tolerability, and safety of two new clinical trails against COVID-19.
About us
The purpose behind the project is to get a new tool to control de pandemic at short-medium and long term. RBDCOV aims to manufacture and test the first recombinant protein-based vaccine to be authorised in Europe beyond the framework of the project. Project funded by the #HorizonEurope programme. During its two years and a half duration, RBDCOV has to guarantee the success of this challenging project, reaching it specific objectives, that are: performing a Phase I/II clinical study of Wuhan variant vaccine in 72 healthy paediatric individuals recruited in Spanish clinical sites; demonstrating the safety and immunogenicity of the new recombinant RBD protein vaccine against the South African and UK variants of SARS-Cov-2 virus in a phase I/II study; manufacturing and tuning COVID-19 recombinant protein vaccines in GMP conditions; designing a clearly path to authorization and commercialization of the vaccine; and involving the general public, as a community, in the project’s design, execution of Phase I/II.
- Industry
- Public Health
- Company size
- 11-50 employees
- Headquarters
- Bruselas
- Type
- Self-Owned
Locations
-
Primary
Get directions
Bruselas, BE
Employees at RBDCOV_EU
Updates
-
#RBDCOVTalks is on the air!🔊 Tune in to listen to leading scientists, researchers, medical professionals, and community advocates. Today, Laura Sesma Aguirre 🔴👉https://lnkd.in/djixhdwg, #InnovationKillsTheVirus #RBDCOV
Need a podcast for summer? 🌞🎧 Check out our #RBDCOVTalks episode with Laura Sesma Aguirre, from Zabala Innovation Europe, discussing our #RBDCOV project and why teamwork and data sharing are central in health research. 🎙️ https://lnkd.in/dvdPNKiM #InnovationKillsTheVirus #COVID19 #COVIDVaccine #BIMERVAX
-
-
To test how well the #BIMERVAX vaccine works, our partner research laboratories at Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and IrsiCaixa have been assessing both the antibody and immune cell responses during the #RBDCOV trials. Have a look at our latest specialised article to learn all about it! 🔴👉https://lnkd.in/diyXDXZ3 #RBDCOV #InnovationKillsTheVirus #immunogenicity
-
-
Need a podcast for summer? 🌞🎧 Check out our #RBDCOVTalks episode with Laura Sesma Aguirre, from Zabala Innovation Europe, discussing our #RBDCOV project and why teamwork and data sharing are central in health research. 🎙️ https://lnkd.in/dvdPNKiM #InnovationKillsTheVirus #COVID19 #COVIDVaccine #BIMERVAX
-
-
Long #COVID is real and still without a cure 📑 Research continues to find treatments for all demographics, including children and adolescents. RBDCOV_EU is contributing by conducting clinical trials across various age groups. Read more 🔎 https://lnkd.in/db264zE6 #InnovationKillsTheVirus #RBDCOV
-
-
News from #ESPID2024! 👀 Check out this interesting poster on #COVID19 risk and severity in children with immunocompromising conditions, based on a population study from Italy and Norway. 📊 Learn about their findings and methods to advance #COVID research 🧬 🔎 https://lnkd.in/ewiBgzw7 #InnovationKillsTheVirus #RBDCOV
-
-
Thanks to the European Commission project extension, we’re advancing in #COVID19 clinical trials: ✔️ Vaccine tested in adults with immunocompromising conditions 🔄 In Progress: Study with adolescents (12-17) 🔜 Next: Study with children (5-11) Know more about our significant results: 🔴👉https://lnkd.in/d5sUSune #InnovationKillsTheVirus #RBDCOV
-
-
Curious about which centres are involved in our study with adolescents aged 12 to 17? 🤔 Here they are: 📌 Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca 📌 Hospital Universitari de Girona Dr. Josep Trueta - Atenció Primària ICS Girona 📌 HM Hospitales - Montepríncipe & Puerta del Sur Hospitals 📌 La Paz Hospital 📌 CAP Peralada 📌 CAP Centelles 👉 https://lnkd.in/d5sUSune #InnovationKillsTheVirus #COVID19 #COVIDVaccine #BIMERVAX
-
-
Stay informed with the latest official statistics about #COVID in the UK! 📊 Check out the National Influenza and COVID-19 reports published weekly by the UK Government. These reports monitor COVID-19 activity, seasonal flu, and other respiratory viruses. 🔎 https://lnkd.in/dMmWErE6 #InnovationKillsTheVirus #RBDCOV
-
Our studies with children and adolescents show #RBDCOV ‘s significant progress in confirming if BIMERVAX® is safe and boosts the immune response to COVID-19. We're close to our goal of 300 volunteers aged 12-17! 👉 https://lnkd.in/ddsnhRC4 #InnovationKillsTheVirus #COVID19 #COVIDVaccine #BIMERVAX
-